Marjan Farid - 31 Oct 2022 Form 3 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role: Director
Signature: /s/ Eric Trachtenberg, Attorney-in-Fact
Issuer symbol: KALA
Transactions as of: 31 Oct 2022
Net transactions value: $0
Form type: 3
Filing time: 01 Nov 2022, 16:11:13 UTC
Next filing: 02 Jun 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney